Mariana based in Cambridge Massachusetts plans to use the new money to advance a pipeline of radiopharmaceutical drugs into clinical testing including its lead candidate for small cell lung cancer. While radiation therapy is a mainstay of cancer care it can come with harsh side effects and can inadvertently damage healthy tissue. By comparison radiopharmaceuticals introduce radiation directly into tumors by pairing a radioactive isotope with a targeting compound